Yanying Liu Selected Research

Peptides (Polypeptides)

12/2019	Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts.
7/2012	Superior molecularly altered influenza virus hemagglutinin peptide 308-317 inhibits collagen-induced arthritis by inducing CD4+ Treg cell expansion.
7/2011	Altered influenza virus haemagglutinin (HA)-derived peptide is potent therapy for CIA by inducing Th1 to Th2 shift.
5/2011	Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome.
9/2010	Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanying Liu Research Topics

Disease

16	Immunoglobulin G4-Related Disease 01/2023 - 12/2017
8	Rheumatoid Arthritis 02/2022 - 07/2011
6	Stroke (Strokes) 02/2020 - 02/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 08/2011
5	Arthritis (Polyarthritis) 01/2022 - 09/2010
5	Ischemic Stroke 01/2021 - 02/2014
4	Neoplasms (Cancer) 03/2024 - 03/2019
4	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 04/2014
4	Brain Injuries (Brain Injury) 01/2021 - 10/2017
4	Neuroinflammatory Diseases 01/2021 - 01/2020
4	Experimental Arthritis 11/2020 - 01/2010
3	Inflammation (Inflammations) 04/2024 - 12/2019
3	Autoimmune Diseases (Autoimmune Disease) 11/2022 - 07/2011
3	Huntington Disease (Huntington's Disease) 11/2017 - 01/2014
2	Eosinophilia 01/2023 - 09/2022
2	Infarction (Infarctions) 01/2021 - 01/2018
2	Ischemia 01/2021 - 10/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 09/2010
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 10/2017
2	CADASIL 01/2015 - 01/2014
1	Neoplasm Metastasis (Metastasis) 05/2024
1	Hyperuricemia 04/2024
1	Alcoholic Fatty Liver 04/2024
1	Gout 04/2024
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2024
1	Hepatocellular Carcinoma (Hepatoma) 03/2024
1	Sialadenitis 03/2024
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Immune System Diseases (Immune Disorders) 01/2023
1	Lymphadenopathy 03/2022
1	Kimura Disease 03/2022
1	Abdominal Aortic Aneurysm 01/2022
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Fibrosis (Cirrhosis) 10/2021
1	Phlebitis 10/2021
1	Autoimmune Pancreatitis 09/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Adenoma (Adenomas) 01/2021
1	Panniculitis 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 11/2020
1	Osteoporosis 01/2020

Drug/Important Bio-Agent (IBA)

13	Immunoglobulin G (IgG)IBA 01/2023 - 12/2017
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2010
5	Immunoglobulin E (IgE)IBA 01/2023 - 12/2017
5	Peptides (Polypeptides)IBA 12/2019 - 09/2010
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 09/2010
4	UbiquitinsIBA 02/2020 - 01/2017
3	GlucocorticoidsIBA 01/2023 - 01/2020
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 02/2020
3	Therapeutic UsesIBA 03/2022 - 01/2010
3	Amyloid (Amyloid Fibrils)IBA 12/2020 - 01/2017
3	AntibodiesIBA 12/2019 - 09/2010
3	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2017 - 04/2014
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 01/2014
3	Stem Cell FactorIBA 01/2016 - 01/2014
2	Uric Acid (Urate)IBA 04/2024 - 04/2024
2	Immunoglobulins (Immunoglobulin)IBA 03/2024 - 01/2023
2	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 01/2022
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2020
2	Protein AggregatesIBA 01/2021 - 10/2017
2	RNA (Ribonucleic Acid)IBA 11/2020 - 12/2017
2	iguratimodIBA 02/2020 - 08/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2020 - 08/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2014
2	alpha-SynucleinIBA 03/2010 - 01/2005
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 05/2024
1	PerforinIBA 04/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Messenger RNA (mRNA)IBA 03/2024
1	Angiopoietin-like ProteinsIBA 03/2024
1	Angiopoietin-Like Protein 4IBA 03/2024
1	AntioxidantsIBA 01/2024
1	CannabidiolIBA 01/2024
1	Complement C3 (C3 Complement)IBA 01/2023
1	Chlorogenic AcidIBA 01/2023
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 01/2023
1	Infliximab (Remicade)FDA Link 02/2022
1	Biosimilar PharmaceuticalsIBA 02/2022
1	tofacitinibIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	GlobulinsIBA 09/2021
1	ORALIT (ORS)IBA 09/2021
1	Serum AlbuminIBA 09/2021
1	Small Heat-Shock ProteinsIBA 01/2021
1	Crystallins (Crystallin)IBA 01/2021
1	CreatinineIBA 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Monoamine Oxidase (MAO)IBA 02/2020
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 02/2020

Therapy/Procedure

12	Therapeutics 01/2023 - 01/2016
1	Intra-Articular Injections 04/2024
1	Biological Therapy 01/2022
1	Drug Tapering 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 11/2020